Skip to content

Observing the Pattern of Symptom Relief in Acute Disease

Reviewing herings direction of cure that symptoms disappear in reverse order of development in acute disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089806
Enrollment
30
Registered
2025-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: Homoeopathic medicine: Homoeopathic Medicine Dose As Per Requirement Of Case Through Sublingual Mode Of Administration Within Time Duration Of 9 Months Control Intervention1: Homoeopath

Sponsors

C D Pachchigar College Of Homoeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient Of Both Sex To Be Considered Irrespective Of Their Socioeconomic Condition And Religion Patients With Their Consent

Exclusion criteria

Exclusion criteria: Chronic Disease And Acute Exacerbation Of Chronic disease Patient With Structural Pathological Changes Patient Suffering From Autoimmune Disease Emergency Cases

Design outcomes

Primary

MeasureTime frame
No Of Cases Showing Symptom Disappearance In Reverse Chronological Order During Recovery as per Herings Direction Of CureTimepoint: 9 Months

Secondary

MeasureTime frame
Time Taken For Complete Symptom Relief After Administration Of A Suitable Homoeopathic Remedy Timepoint: 9 Months;Number Of Cases Not Following Reverse Chronological Order During Recovery as per Herings Direction Of Cure And Their Final OutcomesTimepoint: 9 Months

Countries

India

Contacts

Public ContactDr Asfaqahmed Subedar

Chandravatiben Dhansukhlalpachchigar College Of Homoeopathic Medicine And Hospital

asfaqahmedsubedar@gmail.com9824774456

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026